Cargando…
Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
• First reported case of PPC after BSO in a BRCA1/2-negative, PALB2-positive patient; • The PALB2 mutation and genetic counseling is discussed; • Multi-gene panel testing can benefit prognostic factors and targeted therapy.
Autores principales: | Kahn, Ryan, Garcia-Soto, Arlene, Silva-Smith, Rachel, Pinto, Andre, George, Sophia H.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983106/ https://www.ncbi.nlm.nih.gov/pubmed/27547810 http://dx.doi.org/10.1016/j.gore.2016.08.001 |
Ejemplares similares
-
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
por: Hartley, Taila, et al.
Publicado: (2014) -
PALB2 (partner and localizer of BRCA2)
por: Hanenberg, Helmut, et al.
Publicado: (2018) -
PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response
por: Simhadri, Srilatha, et al.
Publicado: (2018) -
Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2
por: Hartford, Suzanne A., et al.
Publicado: (2016) -
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
por: Kluska, Anna, et al.
Publicado: (2017)